Account
First Partners wins PR Mandate for Dr. Oetker India
MUMBAI: First Partners Communications has won the Public Relations mandate for Dr. Oetker in India. The mandate was awarded after a multi-agency pitching process. The PR mandate extends over digital and traditional media domains along with innovative influencer and stakeholder programs to help crystallise the corporate and brand initiatives of Dr. Oetker and its sub-brand FunFoods.
On the appointment, Dr. Oetker India VP- marketing Devarshy R Ganguly said, “As the leading brand in Western comfort food category in India, we were looking for a communications team that shares our enthusiasm and zeal to grow the category. We found that in First Partners and are happy to bring them on board as our communications partner. We are confident that they will be instrumental in driving our business and brand communication.”
Speaking on the appointment, First Partners founding partner Atul Ahluwalia said, “We are delighted to be a part of Dr. Oetker in this important juncture of their India journey. FunFoods by Dr. Oetker is a household brand in India and it is necessary to build and extend this enviable connect with audiences in the new, young and innovative India. We look forward to a long and successful association with Dr. Oetker.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
